Некто написал,
TEZpWXZFGYUbq
About a year erythromycin stearate 500mg tablet Renaissance Capital's new ETF will track its benchmarkRenaissance IPO Index, according to a May company filing withthe Securities and Exchange Commission. It is expected to havean expense ratio of 60 basis points, roughly a fourth of thecost of its mutual fund cousin, the Renaissance IPO PlusAftermarket Fund, which has an expense ratio of 2.5 percent.


(Читать комментарии)

Добавить комментарий:

Sorry, this entry already has the maximum number of comments allowed.

[ Домой | Написать | Войти/Выход | Поиск | Просмотреть список возможноcтей | Карта сайта ]